| Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different … J Delgado, M Doubek, T Baumann, J Kotaskova, S Molica, P Mozas, ... American journal of hematology 92 (4), 375-380, 2017 | 129 | 2017 |
| Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era A Rivas‐Delgado, L Magnano, M Moreno‐Velázquez, O Garcia, F Nadeu, ... British journal of haematology 184 (5), 753-759, 2019 | 85 | 2019 |
| Mutational landscape and tumor burden assessed by cell-free DNA in diffuse large B-cell lymphoma in a population-based study A Rivas-Delgado, F Nadeu, A Enjuanes, S Casanueva-Eliceiry, P Mozas, ... Clinical Cancer Research 27 (2), 513-521, 2021 | 72 | 2021 |
| European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol A Bataller, A Garrido, F Guijarro, G Oñate, M Diaz-Beyá, M Arnan, ... Blood advances 6 (4), 1193-1206, 2022 | 41 | 2022 |
| Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience P Mozas, F Nadeu, A Rivas-Delgado, A Rivero, M Garrote, O Balagué, ... Blood cancer journal 10 (3), 31, 2020 | 33 | 2020 |
| Past, present and future of prognostic scores in follicular lymphoma P Mozas, A Rivero, A López-Guillermo Blood Reviews 50, 100865, 2021 | 17 | 2021 |
| High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era P Mozas, A Rivas-Delgado, A Rivero, I Dlouhy, F Nadeu, O Balagué, ... Leukemia research 94, 106371, 2020 | 16 | 2020 |
| Clinicobiological characteristics and outcomes of patients with t-cell large granular lymphocytic leukemia and chronic lymphoproliferative disorder of natural killer cells from … A Rivero, P Mozas, L Jiménez, M López-Guerra, D Colomer, A Bataller, ... Cancers 13 (15), 3900, 2021 | 14 | 2021 |
| Is there a role for minimal residual disease monitoring in the management of patients with hairy‐cell leukaemia? V Ortiz‐Maldonado, N Villamor, T Baumann, M Aymerich, L Magnano, ... British Journal of Haematology 183 (1), 2018 | 14 | 2018 |
| Early progression in follicular lymphoma in the absence of histological transformation or high‐risk Follicular Lymphoma International Prognostic Index still has a favourable … A Muntañola, P Mozas, S Mercadal, M Huguet, S Bobillo, M Bastos‐Oreiro, ... British Journal of Haematology 200 (3), 306-314, 2023 | 11 | 2023 |
| The prognostic nutritional index (PNI) is an independent predictor of overall survival in older patients with follicular lymphoma P Mozas, A Rivero, A Rivas-Delgado, F Nadeu, E Giné, J Delgado, ... Leukemia & Lymphoma 63 (4), 903-910, 2022 | 11 | 2022 |
| Follicular lymphoma: an update on diagnosis, prognosis, and management P Mozas, M Sorigué, A López-Guillermo Medicina Clínica (English Edition) 157 (9), 440-448, 2021 | 11 | 2021 |
| Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors P Mozas, C López, M Grau, F Nadeu, G Clot, S Valle, M Kulis, A Navarro, ... Hematological oncology 41 (4), 631-643, 2023 | 10 | 2023 |
| Molecular pathogenesis of follicular lymphoma: from genetics to clinical practice C López, P Mozas, A López-Guillermo, S Beà Hemato 3 (4), 595-614, 2022 | 10 | 2022 |
| Cell-free DNA for genomic analysis in primary mediastinal large B-cell lymphoma A Rivas-Delgado, F Nadeu, M Andrade-Campos, C López, A Enjuanes, ... Diagnostics 12 (7), 1575, 2022 | 10 | 2022 |
| Actualización en el diagnóstico, pronóstico y tratamiento del linfoma folicular P Mozas, M Sorigué, A López-Guillermo Medicina Clínica 157 (9), 440-448, 2021 | 10 | 2021 |
| Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review A Rivero, P Mozas, L Magnano, A Lopez-Guillermo Frontiers in Oncology 13, 1170394, 2023 | 9 | 2023 |
| Long-term responders after autologous stem cell transplantation in multiple myeloma A Oliver-Caldes, JC Soler-Perromat, E Lozano, D Moreno, A Bataller, ... Frontiers in Oncology 12, 936993, 2022 | 9 | 2022 |
| A low lymphocyte-to-monocyte ratio is an independent predictor of poorer survival and higher risk of histological transformation in follicular lymphoma P Mozas, A Rivero, A Rivas-Delgado, F Nadeu, G Clot, JG Correa, ... Leukemia & Lymphoma 62 (1), 104-111, 2021 | 9 | 2021 |
| Prognostic ability of five clinical risk scores in follicular lymphoma: A single‐center evaluation P Mozas, A Rivero, A Rivas‐Delgado, JG Correa, M Condom, F Nadeu, ... Hematological Oncology 39 (5), 639-649, 2021 | 8 | 2021 |